Psoriasis Treatment in Kottayam — Lasting Control
Psoriasis is not a skin problem you manage alone. It is a chronic immune-mediated condition that affects the skin, nails, joints, and overall quality of life. At DermaVue Kottayam, Dr. Sarath Chandran (MD DVL) and Dr. Aji Bowlin Monisha (MD Dermatology, AIIMS Raipur) manage psoriasis across all severity levels — from localized plaque psoriasis responding to topical therapy, to severe erythrodermic presentations requiring biologic intervention. A 2025 real-world study confirms 86.75% of biologic-treated patients achieve complete clearance by week 24.
Types of Psoriasis Treated at DermaVue Kottayam
Each type of psoriasis behaves differently and requires a distinct approach. Plaque psoriasis accounts for approximately 80% of all cases. Scalp psoriasis is one of the most common complaints at DermaVue Kottayam. Accurate classification is the foundation of effective management.
Understanding Psoriasis — The Immune System Perspective
Understanding why psoriasis behaves the way it does — including why it flares and why standard creams alone are insufficient — is key to managing it long-term.
Psoriasis Treatment — Understanding the Condition and Management
How DermaVue Kottayam Manages Psoriasis
Psoriasis management follows a severity-based step-up approach. A 2025 real-world prospective study published in Scientific Reports found that 86.75% of patients on biologic therapy achieved PASI 100 (complete clearance) by week 24. IL-17 inhibitors showed particularly strong performance in real-world settings.
Topical Therapy (Mild–Moderate)
Topical corticosteroids (correct potency for body site), vitamin D analogues (calcipotriol), coal tar for scalp, salicylic acid for scale removal. Steroid rotation protocols prevent tachyphylaxis.
Narrow-Band UVB Phototherapy
Highly effective for moderate-to-severe plaque and guttate psoriasis. 3 sessions per week, 15–30 sessions for clearance. Safe for long-term use. Available at DermaVue Kottayam.
Systemic Therapy (Severe / Refractory)
Methotrexate (weekly oral/injection), cyclosporine for rapid clearance, acitretin for pustular/erythrodermic types. Monitored with monthly blood tests.
Biologics (Targeted Therapy)
IL-17, IL-23, and TNF-alpha inhibitors (adalimumab, secukinumab, ixekizumab) for moderate-to-severe disease. Dramatic clearance in 12–16 weeks. Consultation for eligibility assessment.
Complementary Approach
Safe integration of Ayurvedic supportive care alongside medical treatment where appropriate. Stress management, dietary modifications, and trigger avoidance counselling.
Psoriasis Triggers in Kottayam
- Pre-monsoon heat (March–May) — worst season for flares in this region
- Throat infections (streptococcal) — trigger guttate psoriasis
- Koebner phenomenon — skin injuries trigger new plaques at injury site
- Work stress during fiscal year-end across the Kottayam–Changanacherry corridor
- Alcohol and smoking — both worsen psoriasis outcomes
- Sweating and heat trigger inverse psoriasis in skin folds
The Right and Wrong Way to Use Steroid Creams for Psoriasis
Steroid creams are essential tools in psoriasis management — but misused, they cause more problems than the disease itself. Our dermatologist explains the correct approach.
Topical Steroid Safety in Psoriasis Management — DermaVue
About Psoriasis Treatment at DermaVue Kottayam
DermaVue Kottayam is a physician-owned dermatology clinic in Kerala providing specialist psoriasis treatment under board-certified dermatologists, including an AIIMS-trained specialist. The clinic offers narrowband UVB phototherapy, biologic therapy, and structured severity-based protocols. A 2025 real-world study confirms that 86.75% of biologic-treated patients achieve complete clearance by 24 weeks. Rated 4.8 stars across 558+ reviews, DermaVue serves patients from Kottayam, Ettumanoor, Changanacherry, Pala, Vaikom, and surrounding areas.
Frequently Asked — Psoriasis Treatment Kottayam
Psoriasis is a chronic condition without a permanent cure. However, modern treatments — including biologics — can achieve complete skin clearance in the majority of patients. The goal is sustained remission through ongoing management tailored to your disease severity and lifestyle.
Consultation starts at Rs.300. Treatment costs vary by severity: topical therapy is the most affordable, phototherapy is priced per session course, and biologics represent a higher investment. Our team provides detailed cost information during your initial assessment.
Humidity above 67% actually helps reduce the dryness and scaling typical of psoriasis. However, heat and sweating can trigger inverse psoriasis flares, and the pre-monsoon period (March–May) is consistently the worst season for psoriasis exacerbations in this region.
Biologic agents targeting IL-17 or IL-23 pathways represent the current standard of care for severe psoriasis. A 2025 study showed 86.75% of biologic-treated patients achieved complete clearance by 24 weeks. Methotrexate and cyclosporine remain effective alternatives when biologics are not accessible.
Psoriasis is not contagious. It is an immune-mediated condition driven by genetic predisposition and environmental triggers. You cannot contract psoriasis from touching, sharing personal items, or being near someone who has it. This is a common misconception that causes unnecessary social stigma.
Narrowband UVB phototherapy is effective for moderate psoriasis, with most patients showing significant improvement after 20–30 sessions over 10–15 weeks. It works by suppressing the overactive immune response in the skin. Treatment is supervised by dermatologists who calibrate dosing for your skin type.
Approximately 30% of psoriasis patients develop psoriatic arthritis, which can cause permanent joint damage if untreated. Symptoms include morning stiffness, swollen fingers or toes, and lower back pain. DermaVue screens every psoriasis patient for joint involvement during routine consultations.
Common triggers include pre-monsoon heat and sweating, physical skin injuries (Koebner phenomenon), emotional stress, upper respiratory infections, and certain medications. Alcohol consumption and smoking also worsen outcomes. Identifying your personal triggers helps prevent flares.
Yes. DermaVue Kottayam prescribes and monitors biologic therapy for eligible patients with moderate-to-severe psoriasis. Mandatory pre-treatment screening includes tuberculosis testing, hepatitis panels, and baseline blood work. Ongoing monitoring ensures safety throughout treatment.
Topical therapy shows initial improvement in 2–4 weeks. Phototherapy requires 8–12 weeks for significant clearance. Biologics can produce rapid results — some patients report noticeable improvement within 2–4 weeks, with near-complete clearance by 12–24 weeks depending on the specific agent.
Related Conditions at DermaVue Kottayam
Get Lasting Psoriasis Control in Kottayam
Beyond flare management — a real long-term plan at DermaVue Kottayam. 558+ patients trust our physician-led care.